Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class
Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...
